Allarity Therapeutics Inc (NASDAQ:ALLR) currently has a daily average trading volume of 6.23M but it saw 1580720 shares traded in last market. With a market cap of 6.67M USD, the company’s current market price of $0.16 came rising about 5.56 while comparing to the previous closing price of $0.15. In past 52 weeks, the stock remained buoying in the range of price level as high as $43.60 and as low as $0.14. In the recent trading on the day, stock has struck highest price mark of $0.1477 while lowest mark touched by it was $0.1625.
Taking a look at 20-day trading activity of Allarity Therapeutics Inc (ALLR) gives us an average price of $0.1681, while its current price level is -99.64% below from 52-week high level whereas it is 14.13% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2685 while that of 200 days or SMA-200 reads an average of $5.3376. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.85% during that period while stretching the period over a month that increases to 17.46%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 33.64 which implies that the stock is in neutral territory.
Over the week, ALLR’s stock price is moving 12.74% up while it is -22.57% when we observe its performance for the past one month. Year-to-date it is -98.57% down and over the past year, the stock is showing a downside performance of -99.63%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -44.8 beat the consensus estimate of -163.4 for the same.
Currently, Allarity Therapeutics Inc’s total number of outstanding shares is 42.38M with 0.00% of that held by the insiders while 0.98% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -65.77% and return on equity (ROE) at -121.82%. Stock’s beta reads 0.25. Stock has a price to book (P/B) ratio of 0.28. Its return on asset (ROA) is -52.54% on average.
